NINGBO INNO PHARMCHEM CO.,LTD. is a dedicated supplier of high-quality chemical intermediates essential for the pharmaceutical industry. Among our key offerings is 2-Methylbenzenesulfonic Acid, identified by CAS 88-20-0. This compound, recognized for its high purity (98%) and presented as a fine white powder, plays a significant role in various stages of pharmaceutical research and production. Its utility as a chemical intermediate makes it indispensable for synthesizing a range of therapeutic agents.

The pharmaceutical sector relies heavily on the precision and reliability of its raw materials. 2-Methylbenzenesulfonic Acid offers chemists and researchers a versatile compound that can be used in complex synthesis pathways. Its structural characteristics lend themselves to being a precursor for active pharmaceutical ingredients (APIs) or as a reagent in specific chemical transformations. Understanding the uses of 2-methylbenzenesulfonic acid allows pharmaceutical companies to optimize their manufacturing processes and develop novel drug candidates more efficiently.

For those involved in pharmaceutical development, securing a consistent and dependable supply of critical intermediates like 2-Methylbenzenesulfonic Acid is paramount. NINGBO INNO PHARMCHEM CO.,LTD. is committed to meeting these needs, offering competitive pricing and flexible logistics to support your research and manufacturing timelines. Our focus on quality assurance ensures that every batch of 2-Methylbenzenesulfonic Acid meets stringent industry standards, providing the confidence needed for drug development projects.

The availability of detailed product information, including CAS numbers and application data, is crucial for navigating the complex pharmaceutical landscape. By providing such resources, NINGBO INNO PHARMCHEM CO.,LTD. empowers its clients to make informed decisions. We encourage all pharmaceutical researchers and procurement specialists to explore the potential of 2-Methylbenzenesulfonic Acid and to partner with us for their chemical sourcing needs. This engagement can unlock new possibilities in drug discovery and manufacturing, contributing to advancements in healthcare.